- AnnJi Pharmaceutical avanza AJ201 al ensayo pivotal ROMA-KD de fase 3 para la atrofia muscular espinobulbar (SBMA) La única terapia en investigación conocida para la SBMA en fase 3 de desarrollo a nivel mundial AJ201 (rosolutamida) es una molécula pequeña de administración oral en fase...
Hence then, the article about annji pharmaceutical avanza aj201 al ensayo roma kd para la atrofia muscular espinobulbar was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( AnnJi Pharmaceutical avanza AJ201 al ensayo ROMA-KD para la atrofia muscular espinobulbar )
Also on site :
- Martha Stewart’s Stylish Stoneware Food Container Set Is Perfect for Leftovers, and Just $25 Ahead of Prime Day
- ‘Riverdance’ & ‘Lord of the Dance’ Fans Shocked as Michael Flatley Shares His Wife’s Death at 52: What Happened?
- WBD’s JB Perrette Is Making The Leap To Skydance In Senior Exec Role: Here’s What He’ll Oversee And Why